Results for "Quercetin Senolytic" in Cancer

20 articles

Senolytics Fail to Protect Bone From Chemotherapy-Induced Loss
Cancer Research

Senolytics Fail to Protect Bone From Chemotherapy-Induced Loss

A mouse study finds that senolytic drugs cannot prevent chemotherapy-driven bone loss, challenging a leading hypothesis about its cause.

Research Paper
May 7, 2026 0
New Prodrug and Nano Delivery Systems Target Senescent Cancer Cells
Cancer Research

New Prodrug and Nano Delivery Systems Target Senescent Cancer Cells

Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.

Research Paper
Apr 9, 2026 0
NK Cell Vesicles Deliver One-Two Punch Against Osteosarcoma Using Senolytics
Cancer Research

NK Cell Vesicles Deliver One-Two Punch Against Osteosarcoma Using Senolytics

Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.

Research Paper
Apr 3, 2026 0
Senescent B Cells Drive Cancer Immunotherapy Resistance in Esophageal Cancer
Cancer Research

Senescent B Cells Drive Cancer Immunotherapy Resistance in Esophageal Cancer

Study identifies senescent EGR1+ B cells that sabotage immunotherapy in esophageal cancer, with fisetin showing promise as a therapeutic enhancer.

Research Paper
Apr 2, 2026 0
Hidden Protein Shields Liver Cancer Cells From a Key Cell Death Pathway
Cancer Research

Hidden Protein Shields Liver Cancer Cells From a Key Cell Death Pathway

Scientists uncover how SCRN1 blocks ferroptosis in liver cancer, revealing new targets for treating drug-resistant hepatocellular carcinoma.

Research Paper
May 22, 2026 0
Senescent Tumor Cells Expressing PD-L2 Blunt Chemotherapy Effectiveness
Cancer Research

Senescent Tumor Cells Expressing PD-L2 Blunt Chemotherapy Effectiveness

Intratumoral senescent cells shielded by PD-L2 may explain why chemotherapy often falls short — and point to a new combination strategy.

Research Paper
Jun 3, 2026 0
Urine Test May Soon Track Senescent Cells in Cancer and Fibrosis
Cancer Research

Urine Test May Soon Track Senescent Cells in Cancer and Fibrosis

Cambridge scientists engineer a nanoprobe that detects therapy-induced senescence non-invasively through a simple urine colorimetric test.

Research Paper
May 14, 2026 0
Lysosomal Disruption Boosts Cancer Drug Effectiveness Against RNA Polymerase
Cancer Research

Lysosomal Disruption Boosts Cancer Drug Effectiveness Against RNA Polymerase

Researchers discover how cancer cells use lysosomes to resist RNA polymerase inhibitors and develop combination strategies to overcome this resistance.

Research Paper
Apr 2, 2026 0
PROTAC Nanomedicine Destroys Cancer Protein to Trigger Cell Death via Ferroptosis
Cancer Research

PROTAC Nanomedicine Destroys Cancer Protein to Trigger Cell Death via Ferroptosis

Novel nanoparticle combines protein degrader with light therapy to reprogram cancer metabolism and eliminate breast tumors.

Research Paper
Apr 4, 2026 0
Common Supplement PQQ Found to Block Cancer-Driving Enzyme in Lymphoma Cells
Cancer Research

Common Supplement PQQ Found to Block Cancer-Driving Enzyme in Lymphoma Cells

PQQ, a widely available dietary supplement, inhibits EZH2 and suppresses B-cell lymphoma proliferation in lab studies.

Research Paper
Apr 23, 2026 0
PQQ Shows Anticancer Promise But Needs Clinical Trials to Prove It
Cancer Research

PQQ Shows Anticancer Promise But Needs Clinical Trials to Prove It

Pyrroloquinoline quinone has demonstrated anticancer activity in preclinical studies, but human cancer trials remain absent. Here's where the science stands.

Research Paper
Apr 24, 2026 0
Mitochondria-Targeted Nanozyme Triggers Dual Cancer Cell Death Pathways
Cancer Research

Mitochondria-Targeted Nanozyme Triggers Dual Cancer Cell Death Pathways

Novel nanoplatform delivers copper and iron ions to trigger both ferroptosis and cuproptosis in cancer cells.

Research Paper
Apr 7, 2026 0
RNA Polymerase Inhibitor CX-5461 Triggers Cancer Cell Death via Iron Overload
Cancer Research

RNA Polymerase Inhibitor CX-5461 Triggers Cancer Cell Death via Iron Overload

New study reveals how blocking ribosome production makes cancer cells vulnerable to ferroptosis, an iron-dependent cell death pathway.

Research Paper
Apr 4, 2026 0
Ferroptosis Boosts Anti-Tumor Immunity by Degrading the Immune Suppressor SHP2
Cancer Research

Ferroptosis Boosts Anti-Tumor Immunity by Degrading the Immune Suppressor SHP2

RSL3-induced ferroptosis degrades SHP2 via chaperone-mediated autophagy, amplifying IFN-γ/STAT1 signaling and enhancing anti-PD-1 immunotherapy efficacy.

Research Paper
May 22, 2026 0
Chemotherapy Awakens Dormant Cancer Cells Through Neutrophil Traps
Cancer Research

Chemotherapy Awakens Dormant Cancer Cells Through Neutrophil Traps

Study reveals how common cancer drugs trigger dormant tumor cells to reactivate and spread, offering new prevention strategies.

Research Paper
Mar 29, 2026 1
New Macrocyclic Peptides Selectively Kill Chemotherapy-Resistant Lung Cancer Cells
Cancer Research

New Macrocyclic Peptides Selectively Kill Chemotherapy-Resistant Lung Cancer Cells

Orally bioavailable cyclin A/B RxL inhibitors exploit a cell-cycle vulnerability in small-cell lung cancer and other G1-S-checkpoint-deficient tumors.

Research Paper
May 18, 2026 0
Ginseng Compound Rh4 Fights Colorectal Cancer by Reshaping Gut Bacteria and Bile Acids
Cancer Research

Ginseng Compound Rh4 Fights Colorectal Cancer by Reshaping Gut Bacteria and Bile Acids

Ginsenoside Rh4 suppresses colorectal cancer by boosting Akkermansia muciniphila and elevating protective bile acid UDCA via FXR signaling.

Research Paper
Jun 1, 2026 0
Antidepressants Sertraline and Indatraline Trigger Cancer Cell Death via Cholesterol
Cancer Research

Antidepressants Sertraline and Indatraline Trigger Cancer Cell Death via Cholesterol

Two common antidepressants cause cholesterol buildup in cancer cell lysosomes, triggering immunogenic cell death that helps immune system fight tumors.

Research Paper
Apr 5, 2026 0
New Strategy Boosts Cancer Drug Effectiveness by Preventing Protein Breakdown
Cancer Research

New Strategy Boosts Cancer Drug Effectiveness by Preventing Protein Breakdown

Researchers found that stopping HER2 protein degradation significantly improves trastuzumab deruxtecan cancer treatment outcomes.

Research Paper
Mar 29, 2026 3
Exosomes from senescent cells could revolutionize cancer therapy delivery
Cancer Research

Exosomes from senescent cells could revolutionize cancer therapy delivery

New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.

Research Paper
Apr 9, 2026 0
Page 1 of 2Next